CIK: 0001964437 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $133,889 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CYMABAY THERAPEUTICS INC | 1,629,464 | $14,209 | 10.6% | $3.60 | — | Common | 23257D103 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 741,043 | $11,901 | 8.9% | $17.76 | +4.2% | Common | 22663K107 |
| — | CHINOOK THERAPEUTICS INC | 506,818 | $11,733 | 8.8% | $17.10 | — | Common | 16961L106 |
| — | HORIZON THERAPEUTICS PLC | 99,217 | $10,829 | 8.1% | $90.31 | — | SHS | G46188101 |
| BIIB | BIOGEN INC(NSM) | 37,459 | $10,415 | 7.8% | $277.87 | -0.4% | Common | 09062X103 |
| CYTK | CYTOKINETICS INC | 282,886 | $9,955 | 7.4% | $42.30 | -3.6% | Common | 23282W605 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,163,535 | $9,704 | 7.2% | $10.46 | -7.9% | Common | 09058V103 |
| — | MORPHIC HOLDING INC | 246,616 | $9,283 | 6.9% | $27.33 | — | Common | 61775R105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,121,982 | $8,819 | 6.6% | $6.11 | +22.1% | Common | 483497103 |
| ASND | ASCENDIS PHARMA A/S - ADR | 77,210 | $8,278 | 6.2% | $115.24 | — | Sponsored ADR | 04351P101 |
| APLS | APELLIS PHARMACEUTICALS INC | 123,165 | $8,124 | 6.1% | $53.04 | +8.8% | Common | 03753U106 |
| — | ITEOS THERAPEUTICS INC | 480,653 | $6,542 | 4.9% | $18.55 | — | Common | 46565G104 |
| — | SAGE THERAPEUTICS INC | 145,018 | $6,085 | 4.5% | $34.39 | — | Common | 78667J108 |
| FOLD | AMICUS THERAPEUTICS INC(NMS) | 258,288 | $2,864 | 2.1% | $11.26 | +9.5% | Common | 03152W109 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 178,217 | $1,960 | 1.5% | $17.47 | -17.2% | Common | 03969K108 |
| — | 2SEVENTY BIO INC | 172,188 | $1,756 | 1.3% | $14.43 | — | Common | 901384107 |
| — | ASTRIA THERAPEUTICS INC | 101,339 | $1,348 | 1.0% | $9.18 | — | Common | 04635X102 |
| — | SCILEX HOLDING CO(NAS) | 10,390 | $85 | 0.1% | $8.20 | — | Common | 80880W106 |